CollPlant Biotechnologies announced on February 24, 2025, the expansion of its distribution channels for its Vergenix™ STR product in Europe and Asia. The company signed new distribution agreements with partners in the Netherlands, Turkey, and India.
These agreements cover sales in the territories of the Netherlands, Belgium, Luxembourg (Benelux), Spain, India, and Turkey. The first shipment to the Benelux and Spain distributor was made in February 2025, indicating immediate market entry in these regions.
VergenixSTR is a soft tissue repair matrix based on CollPlant's rhCollagen technology, intended for the treatment of tendinopathy. This expansion broadens the commercial footprint for the product, offering a differentiated treatment for tendon injuries by promoting healing and repair.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.